Status:

Red

Decision Date:

October 2024

Comments

RED:

NICE TA1003 - for treating transfusion-dependent beta-thalassaemia in people 12 years and over (Decision date - October 2024) 

NICE TA1044: Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over (decision date March 25)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again